Use of first or second generation TKI for CML after allogeneic hematopoietic stem cell transplantation: A study by the CMWP of the EBMT

被引：0

作者：

Chalandon, Y.

Iacobelli, S. ^{[1
]}

Hoek, J. ^{[2
]}

Koster, L. ^{[2
]}

Volin, L. ^{[3
]}

Finke, J. ^{[4
]}

Cornelissen, J. J. ^{[5
]}

Yakoub-Agha, I. ^{[6
]}

Craddock, C. ^{[7
]}

Aljurf, M. ^{[8
]}

Nagler, A. ^{[9
]}

Passweg, J. ^{[10
]}

Meijer, E. ^{[11
]}

Crawley, C. ^{[12
]}

Hunter, A. E. ^{[13
]}

Afanasyev, B. ^{[14
]}

Keonecke, C. ^{[15
]}

Schaap, N. P. M. ^{[16
]}

De Groot, M. R. ^{[17
]}

Schleuning, M. ^{[18
]}

Olavarria, E. ^{[19
]}

Kroeger, N. ^{[20
]}

机构：

[1] Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy

[2] Dept Med Stat & Bioinformat, Leiden, Netherlands

[3] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland

[4] Univ Freiburg, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany

[5] Erasmus MC, Inst Canc, Dept Hematol, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands

[6] Univ Lille2, U995, INSERM, CHU Lille,LIRIC, F-59000 Lille, France

[7] Queen Elizabeth Hosp Edgbaston, Ctr Clin Haematol, Birmingham B15 2TH, W Midlands, England

[8] King Faisal Specialist Hosp & Res Ctr, POB 3354, Riyadh, Saudi Arabia

[9] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[10] Univ Hosp Basel, Dept Biomed & Clin Res, Div Hematol, Petersgraben 4, Basel, Switzerland

[11] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

[12] Addenbrookes Hosp, Cambridge, England

[13] Leicester Royal Infirm, 576 Derby Rd, Leicester, Leics, England

[14] St Petersburg Pavlov State Med Univ, Mem RM Gorbacheva Inst Children Hematol & Transpl, St Petersburg, Russia

[15] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Carl Neuberg Str 1, D-30615 Hannover, Germany

[16] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Geert Grootepl 8,POB 9101, NL-6500 HB Nijmegen, Netherlands

[17] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands

[18] Deutsche Klin Diagnost, HELIOS Klin, Wiesbaden, Germany

[19] Imperial Coll London, Hammersmith Hosp, Ctr Haematol, Du Cane Rd, London W12 0HS, England

[20] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Martinistr 52, D-20246 Hamburg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2017年 / 52卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P584

引用

页码：S427 / S428

页数：2

共 50 条

[1] Use of First or Second Generation TKI for CML after Allogeneic Stem Cell Transplantation: a Study By the CMWP of the EBMT
Chalandon, Yves
Iacobelli, Simona
Hoek, Jennifer
Koster, Linda
Volin, Liisa
Finke, Jurgen
Cornelissen, Jan J.
Yakoub-Agha, Ibrahim
Craddock, Charles
Aljurf, Mahmoud
Nagler, Arnon
Passweg, Jakob
Meijer, Ellen
Crawley, Charles
Hunter, Ann Elizabeth
Afanasyev, Boris
Koenecke, Christian
Schaap, Nicolaas P. M.
De Groot, Marco R.
Schleuning, Michael
Olavarria, Eduardo
Kroger, Nicolaus
BLOOD, 2016, 128 (22)
[2] Allogeneic stem cell transplantation in patients with CML-CP in the era of third generation tyrosine kinase inhibitors: a study by the CMWP of the EBMT
Chalandon, Yves
Sbianchi, Giulia
Hoek, Jennifer
Apperley, Jane
Itala-Remes, Maija
Markiewicz, Miroslaw
Byrne, Jenny
Sengeloev, Henrik
Chaudri, Naeem
Malladi, Ram
Remenyi, Peter
de Groot, Marco
Snowden, John
Robin, Marie
Ljungman, Per
Schaap, Nicolaas
Lenhoff, Stig
Passweg, Jakob
Maertens, Johan
Cornelissen, J. J.
Yakoub-Agha, Ibrahim
Ayuk, Francis
Afanasyev, Boris
Olavarria, Eduardo
Kroeger, Nicolaus
SWISS MEDICAL WEEKLY, 2018, 148 : 4S - 4S
[3] Allogeneic stem cell transplantation in patients with CML-CP in the era of third generation tyrosine kinase inhibitors: a study by the CMWP of the EBMT
Chalandon, Yves
Sbianchi, Giulia
Hoek, Jennifer
Apperley, Jane
Itala-Remes, Maija
Markiewicz, Miroslaw
Byrne, Jenny
Sengeloev, Henrik
Chaudri, Naeem
Malladi, Ram
Remenyi, Peter
de Groot, Marco
Snowden, John
Robin, Marie
Ljungman, Per
Schaap, Nicolaas
Lenhoff, Stig
Passweg, Jakob
Maertens, Johan
Cornelissen, Jan
Yakoub-Agha, Ibrahim
Ayuk, Francis
Afanasyev, Boris
Kroeger, Nicolaus
BONE MARROW TRANSPLANTATION, 2018, 53 : 45 - 46
[4] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LOWER RISK MDS PATIENTS : A RETROSPECTIVE STUDY ON BEHALF OF THE CMWP OF THE EBMT
Robin, M.
Porcher, R.
Zinke, W.
Van Biezen, A. N. J. A.
Volin, L.
Mufti, G.
Craddock, C.
Finke, J.
Richard, C.
Passweg, J.
Peniket, A.
Martens, J.
Sucak, G.
Gedde-Dahk, T.
Vitek, A.
Nagler, A.
Blaise, D.
Beelen, D.
Maillard, N.
Schwerdtfeger, R.
Iacobelli, S.
De Witte, T.
Kroger, N.
LEUKEMIA RESEARCH, 2015, 39 : S68 - S69
[5] Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)
Machate, Nora
Alchalby, Haefaa
Sehner, Susanne
Zabelina, Tatjana
Wolff, Daniel
Kobbe, Guido
Bornhaeuser, Martin
Baurmann, Herrad
Bethge, Wolfgang A.
Wulf, Gerald
Zander, Axel R.
Kroeger, Nicolaus
BLOOD, 2013, 122 (21)
[6] Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT
Vincent, Laure
Gras, Luuk
Ceballos, Patrice
Finke, Jurgen, Sr.
Passweg, Jakob
Robin, Marie
Rosinol, Laura
Minnema, Monique C.
Teipel, Raphael
Van Deosum, J. A.
Haenel, Mathias
Lenain, Pascal
Forcade, Edouard
Koenecke, Christian
Ducastelle, Sophie
Sanz, Jaime
Schroyens, Wilfried
Zuckerman, Tsila
Ladetto, Marco
Koster, Linda
de Wreede, Liesbeth C.
Hayden, Patrick J.
Schonland, Stefan
Yakoub-Agha, Ibrahim
Beksac, Meral
BLOOD, 2020, 136
[7] Allogeneic stem cell transplantation for CML in the era of TKI
Passweg, J.
Heim, D.
ONKOLOGIE, 2010, 33 : 109 - 109
[8] Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Kroeger, Nicolaus
Sbianchi, Giulia
Sirait, Tiarlan
Wolschke, Christine
Beelen, Dietrich
Passweg, Jakob
Robin, Marie
Vrhovac, Radovan
Helbig, Grzegorz
Sockel, Katja
Conneally, Eibhlin
Rubio, Marie Therese
Beguin, Yves
Finke, Juergen
Bernasconi, Paolo
Morozova, Elena
Clausen, Johannes
von dem Borne, Peter
Schaap, Nicolaas
Schroyens, Wilfried
Patriarca, Francesca
Di Renzo, Nicola
Yegin, Zeynep Arzu
Hayden, Patrick
McLornan, Donal
Yakoub-Agha, Ibrahim
LEUKEMIA, 2021, 35 (12) : 3551 - 3560
[9] Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger
Giulia Sbianchi
Tiarlan Sirait
Christine Wolschke
Dietrich Beelen
Jakob Passweg
Marie Robin
Radovan Vrhovac
Grzegorz Helbig
Katja Sockel
Eibhlin Conneally
Marie Thérèse Rubio
Yves Beguin
Jürgen Finke
Paolo Bernasconi
Elena Morozova
Johannes Clausen
Peter von dem Borne
Nicolaas Schaap
Wilfried Schroyens
Francesca Patriarca
Nicola Di Renzo
Zeynep Arzu Yeğin
Patrick Hayden
Donal McLornan
Ibrahim Yakoub-Agha
Leukemia, 2021, 35 : 3551 - 3560
[10] TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP)
de Lavallade, Hugues
Eikema, Dirk-Jan
Hoek, Jennifer
Robin, Marie
Itala-Remes, Maija
Passweg, Jakob
Cornelissen, J.
Ganser, Arnold
Craddock, Charles
Aljurf, Mahmoud
Choi, Goda
Nagler, Arnon
Kroeger, Nicolaus
Browne, Paul
Dreger, Peter
Scheid, Christof
Verbeek, Mareike
Finke, Juergen
Chalandon, Yves
Yakoub-Agha, Ibrahim
BONE MARROW TRANSPLANTATION, 2019, 54 : 52 - 54

← 1 2 3 4 5 →